ARIA

Name

ARIA

Legal name

Advanced Research and Invention Agency

Website

https://www.aria.org.uk

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Government R&D Funding

NAICS

Management, Scientific, and Technical Consulting Services (5416)

SIC

Services-Engineering, Accounting, Research, Management (8700)

akta.pro primary industry

Micro-VC & Angel Funds (FSANAAAI)

akta.pro secondary industry

Research Administration & Grants Management Support (Pre/Post-Award, Compliance) (EDAEALAO)

Keywords

• R&D funding agency
• Government research grants
• High-risk research funding
• Science breakthrough programmes
• Innovation seed funding

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Others, Personnel, Operations, Technology or R&D

Revenue model

1. Government Funding Allocation: ARIA receives funding from the UK Government through the Department for Science, Innovation and Technology. In the June 2025 Spending Review, ARIA was allocated at least £1 billion to grow its scope and capabilities. The agency deploys this funding through programmes (£10-100M each) and opportunity seeds (up to £500k per project).

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

ARIA is the UK's R&D funding agency that provides grants and seed funding for high-risk, high-reward scientific and technological research. It empowers Programme Directors with significant autonomy to design multi-year programmes (£10-100M each) and opportunity seeds (up to £500k) across defined opportunity spaces such as AI safety, neurotechnology, climate science, and synthetic biology. ARIA funds academic researchers, startups, and individual innovators, while retaining limited IP rights and providing 100% FEC for academic institutions.

Product overview

ARIA (Advanced Research and Invention Agency) is the UK's R&D funding agency that operates through a portfolio of interconnected funding mechanisms rather than a traditional product offering. The core offerings consist of Opportunity Spaces (14 defined research domains), Programmes (multi-year £10-100m initiatives directed by Programme Directors), and Opportunity Seeds (up to £500k early-stage funding). Supporting infrastructure includes Activation Partners (science translation support), Innovator Circles (technical peer communities), and AI in Science initiatives. The AI Scientists programme funds autonomous AI systems for scientific discovery. All funding activities are managed through the ARIA Grant Platform. This structure enables ARIA to fund breakthrough R&D across diverse fields from innate immunity to climate engineering, with each opportunity space representing fertile ground for technical breakthroughs.

Differentiator

Problem solved

Functional benefit

Products and services

• Opportunity Spaces

Named customers11 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Google DeepMindcoreStrategic or Co-development Partner · 11 June 2026ARIA partnered with Google DeepMind, Schmidt Sciences, Cooperative AI Foundation, and Google.org for a $10M funding initiative to study risks posed by multi-agent AI systems where millions of AI agents interact without human oversight.
• Cooperative AI FoundationcoreStrategic or Co-development Partner · 11 June 2026ARIA partnered with Cooperative AI Foundation as part of a $10M initiative to study multi-agent AI system risks, with researchers expected to run realistic simulations dropping AI agents into sandboxes.
• Convergent ResearchminorStrategic or Co-development Partner · 21 April 2026ARIA and Convergent Research launched two UK Focused Research Organizations (FROs): Meridial and Echo Labs, aimed at building scientific infrastructure for living-brain connectivity mapping and ecological intelligence.
• CommonAIcoreStrategic or Co-development Partner · 26 February 2026ARIA joined CommonAI with an initial €18M grant (part of €57M total commitment) to establish a Scaling Inference Lab focused on strengthening UK's AI inference capabilities. The lab will operate inside live data-center environments with the goal of reducing compute costs by 1000x.
• Activation Partners (9 founding partners)coreStrategic or Co-development Partner · 1 April 2025ARIA's Activation Partners inject entrepreneurial talent, capital, and ideas to help propel research. Founding partners include organizations working across science translation, venture creation, and ecosystem development. Second cohort of up to 10 partners launched with £100M call.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• DARPA (Defense Advanced Research Projects Agency): DARPA is the direct model and inspiration for ARIA, providing high-risk, high-reward research funding through Programme Managers with significant budget autonomy. ARIA was explicitly modeled after DARPA, and its new CEO Kathleen Fisher is a former DARPA director. They share mandate, structure, and operational philosophy, though DARPA operates at much larger scale and focuses on defense applications.
• BARDA (Biomedical Advanced Research and Development Authority): BARDA funds advanced research and development of medical countermeasures (vaccines, therapeutics, diagnostics) using a programmatic approach. ARIA's Sustained Viral Resilience and Sculpting Innate Immunity programmes overlap BARDA's pandemic preparedness mandate, though BARDA is a much larger US federal agency.
• HHMI (Howard Hughes Medical Institute): HHMI is one of the largest biomedical research organizations, funding investigators and bold science. ARIA shares HHMI's commitment to funding high-risk research and supporting individual investigators with significant autonomy. HHMI is broader in scope (biomedical only) but operates at much larger scale.
• European Research Council (ERC): The ERC funds exploratory, high-risk research across Europe through grants to individual researchers. While ARIA uses Programme Directors and structured programmes rather than individual investigator grants, both target high-risk, high-reward research that conventional funders avoid.

Direct peers

• ARPA-E (Advanced Research Projects Agency - Energy): ARPA-E is the US Department of Energy's equivalent of DARPA, funding high-risk, high-reward energy technology research. It uses the same Programme Director model with significant autonomy. ARIA's energy-adjacent opportunity spaces (Future Proofing Our Climate and Weather, Bioenergetic Engineering) directly overlap ARPA-E's mandate.
• Schmidt Sciences: Schmidt Sciences is a philanthropic initiative funding high-risk research in AI, science, and technology, with a focus on fields underexplored by traditional funders. ARIA has partnered with Schmidt Sciences on a $10M multi-agent AI risk study. They share a mandate to fund breakthrough research outside conventional funding channels.
• Wellcome Leap: Wellcome Leap funds bold, breakthrough health research at scale using a programmatic model similar to ARIA, with multi-year programmes and significant per-programme budgets. Both target high-risk research that traditional funders avoid, and both emphasize measurable, ambitious outcomes.
• Convergent Research: Convergent Research operates Focused Research Organizations (FROs) and recently partnered with ARIA to launch two UK FROs (Meridial and Echo Labs). Both share a model of creating purpose-built research organizations to tackle specific scientific challenges outside traditional academic structures.
• CommonAI: CommonAI is a UK-based AI infrastructure initiative that ARIA joined as a member with an initial £16M grant (part of £50M total) to establish the Scaling Inference Lab. Both target foundational UK AI capabilities and share a mission-oriented funding approach.

Emerging players

• Entrepreneur First: Entrepreneur First supports creation of technology companies globally through talent identification and venture creation. ARIA's Deputy CEO Pippy James was previously Global Product Manager at Entrepreneur First, and Activation Partners include similar science-translation and venture-creation organizations. Both focus on translating research into commercial outcomes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key highlights7 records

Customer concentration

• Xx.com/ARIA_research
• LinkedInlinkedin.com/company/advanced-research-and-invention-agency

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments15 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ARIA